Instituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2022

  1. Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer’s Disease Patients

    Frontiers in Immunology, Vol. 13

  2. Saliva is a Good Candidate to be the New Gold-Standard Sample for Neurodegenerative Diseases

    Journal of Alzheimer's Disease, Vol. 87, Núm. 4, pp. 1497-1501

2021

  1. Cost-effectiveness analysis of text messaging to support health advice for smoking cessation

    Cost Effectiveness and Resource Allocation, Vol. 19, Núm. 1

2017

  1. Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin

    Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 8, pp. 131-138